• News
  • Contact Us

Is Your Company Worth the Risk: Making Your Start-up Device or Biotech Company Attractive for Investors.

Seminars and Conferences

07/16/2008 7:30 AM - 07/16/2008 9:00 AM
Union League

What attracts venture capitalists to fund certain start-ups and not others? Many of today's leading medical device and biotech companies began as start-ups funded by VCs who took a risk. This seminar will provide a forum for discussion of how lower-risk strategies combined with successful commercial marketing plans can be achieved to help entrepreneurs attract the capital vital to a start-up's success. Members of the business community who have played critical roles in bringing start-ups to fruition will provide key expertise on this subject.

Highlights that will be discussed by this panel include:

  • The real-life experiences of CEOs in growing an early-stage company
  • What criteria do investors use to evaluate a biotech or device start-up?
  • At what stage should VCs be approached?
  • What concerns VCs when considering their next investment?
  • How important is it for the start-up to have other products in the pipeline?
  • What role does patent protection play in the consideration of funding?
  • How to differentiate your start-up to make it attractive for funding
David W. Anderson
President and CEO, Gentis, Inc.
David R. King
Venture Partner, Quaver BioVentures

Please join us at The Union League for this panel presentation. A continental breakfast will be served at 7:30am.

To Register: Click Here